Feed / CCCC

C4 Therapeutics, Inc.

CCCC

Healthcare · 4.11 +5.0% today

Participation confirmed · construction unavailableMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

C4 Therapeutics, Inc.'s move is being confirmed by its market group.

No new filing conclusion is available. 28 of 31 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.

Company+5.0% todayVolume comparison unavailable
Market group28 of 31 activeBiotechnology Therapeutics · active
Disclosed network0 of 3 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 21 of 31 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as NRIX begins moving with the group.

Invalidation: The live read weakens if participation falls to 10 of 31 members or fewer.

Watch this read

Who this business touches

The relationships behind CCCC

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

MRKMerck & Company, Inc.partnerMay 12, 2026

Merck KGaA Collaboration and License Agreement In March 2024, we entered into a license and collaboration agreement with Merck KGaA, or the Merck KGaA Agreement, to discover two targeted protein degraders against critical oncogenic proteins.

BIIBBiogen Inc.partnerMay 12, 2026

Target Platform Collaborations We work or have worked with strategic partners to expand our platform potential, including Roche, Biogen, Merck Sharp & Dohme, LLC, or Merck, and Merck KGaA.

PFEPfizer, Inc.partnerMay 12, 2026

We are currently advancing cemsidomide in the Phase 2 MOMENTUM trial in combination with dexamethasone and the Phase 1b trial in combination with dexamethasone and elranatamab, which we are conducting pursuant to the Pfizer Agreement.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

CCCC is currently a Participant in the organic co-movement group Biotechnology Therapeutics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.